PSP

Clinical trials for PSP explained in plain language.

Never miss a new study

Get alerted when new PSP trials appear

Sign up with your email to follow new studies for PSP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 3 Completed 1

Hope for PSP: experimental drug AMX0035 put to the test

Disease control Completed

This study tested whether the drug AMX0035 can slow down or improve symptoms of Progressive Supranuclear Palsy (PSP), a rare brain disease that affects movement, balance, and thinking. About 139 adults aged 40 to 80 with early-stage PSP took either the drug or a placebo for sever…

Matched conditions: PSP

Phase: PHASE2, PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

PSP

Get alerted when new PSP trials appear

Hope for PSP: experimental drug AMX0035 put to the test